View or download posters and publications from 4D pharma plc
Archive:
Date | 08 Jan 2021 |
---|---|
Title | Publication - The fecal mycobiome in patients with Irritable Bowel Syndrome, Scientific Reports |
Document | — |
Link | visit |
Date | 09 Nov 2020 |
---|---|
Title | SITC2020, 4D presents first monotherapy data for immuno-oncology LBP MRx0518 in neoadjuvant setting, demonstrating tumor and systemic immune modulation |
Document | (842KB) |
Link | — |
Date | 09 Nov 2020 |
Title | SITC2020, 4D presents updated clinical benefit results from Part A of its trial of MRx0518 in combination with pembrolizumab in refractory solid tumors |
Document | (488KB) |
Link | — |
Date | 09 Nov 2020 |
Title | SITC2020, trial-in-progress (TiP) poster describing ongoing Part B of its Phase I/II trial of MRx0518 in combination with pembrolizumab in refractory solid tumors |
Document | (461KB) |
Link | — |
Date | 07 Jun 2020 |
Title | 4D presents preclinical LBP candidates for neurodegenerative disease and autism at Microbiome Connect Human USA |
Document | (2,781KB) |
Link | — |
Date | 29 Apr 2020 |
Title | 4D and OncoDesign present joint AACR poster with additional analysis of MRx0518 activity in pre-clinical model of breast cancer |
Document | (647KB) |
Link | — |
Date | 21 Mar 2020 |
Title | Publication - Quality by Design: comparison of design space construction methods in the case of Design of Experiments |
Document | — |
Link | visit |
Date | 16 Dec 2019 |
---|---|
Title | Publication - Differences in the microbiome and metabolome of people with irritable bowel syndrome and bile acid malabsorption |
Document | — |
Link | visit |
Date | 06 Dec 2019 |
Title | 4D presents at the Microbiome Movement Gut-Brain-Axis Summit in Boston |
Document | (2,651KB) |
Link | — |
Date | 06 Dec 2019 |
Title | 4D presents on the immunology of MRx-4DP0004 in vitro and in a model of severe asthma, at the British Society of Immunology Congress 2019 |
Document | (835KB) |
Link | — |
Date | 06 Dec 2019 |
Title | 4D presents the preclinical anti-tumour activity and immunology of immuno-oncology LBP MRx0518 at the British Society for Immunology 2019 |
Document | (704KB) |
Link | — |
Date | 14 Nov 2019 |
Title | 4D presents at the European Microbiome Congress, on LBPs targeting the gut-brain axis |
Document | (2,410KB) |
Link | — |
Date | 11 Nov 2019 |
Title | 4D present trial-in-progress poster at SITC 2019, detailing Phase I study of neoadjuvant MRx0518 before surgical resection of solid tumours |
Document | (587KB) |
Link | — |
Date | 24 Oct 2019 |
Title | 4D presents pre-clinical data on two candidates for neurodegenerative disease at Neuroscience 2019 |
Document | (789KB) |
Link | — |
Date | 10 Oct 2019 |
Title | 4D pharma presents on bacterial SCFA metabolites as HDAC inhibitors |
Document | (783KB) |
Link | — |
Date | 10 Oct 2019 |
Title | 4D pharma presents additional analysis of Blautix Phase Ib study in IBS |
Document | (772KB) |
Link | — |
Date | 10 Oct 2019 |
Title | 4D pharma presents pre-clinical data on two LBP candidates for neurodegenerative disease |
Document | (673KB) |
Link | — |
Date | 20 Sep 2019 |
Title | Publication - In vitro Characterization of Gut Microbiota-Derived Bacterial Strains With Neuroprotective Properties |
Document | — |
Link | visit |
Date | 09 Sep 2019 |
Title | Publication - Identification performance of MALDI-ToF-MS upon mono- and bi-microbial cultures is cell number and culture proportion dependent |
Document | — |
Link | visit |
Date | 25 Jul 2019 |
Title | 4D pharma presents new mechanistic data for oncology programmes |
Document | (3,248KB) |
Link | — |
Date | 25 Jul 2019 |
Title | 4D pharma presentation at Oncology Response Summit 2019. Into the Clinic: Challenges & Opportunities |
Document | (1,294KB) |
Link | — |
Date | 20 Jun 2019 |
Title | 4D pharma presents at Keystone Symposia:Neurodegenerative Diseases: New Insights and Therapeutic Opportunities, USA |
Document | (1,475KB) |
Link | — |
Date | 07 Jun 2019 |
Title | 4D Presents Phase Ib Clinical Data on Thetanix® at ESPGHAN |
Document | (1,511KB) |
Link | — |
Date | 03 Jun 2019 |
Title | 4D presents MRx0518 combination study at ASCO 2019, Chicago, USA |
Document | (581KB) |
Link | — |
Date | 21 May 2019 |
Title | 4D presents on lead immuno-oncology candidate MRx0518 at 4th Annual Advances in Immuno-Oncology Congress, London, UK |
Document | (3,895KB) |
Link | — |
Date | 19 May 2019 |
Title | 4D Presents Phase Ib Clinical Data on Thetanix® at Digestive Disease Week, San Diego |
Document | (664KB) |
Link | — |
Date | 13 May 2019 |
Title | 4D announces participation in Neuro4D Conference, Frankfurt, Germany |
Document | (629KB) |
Link | — |
Date | 08 Mar 2019 |
Title | 4D announces participation in Chardan’s Inaugural Microbiome Medicines Summit, USA |
Document | — |
Link | visit |
Date | 30 Jan 2019 |
Title | 4D pharma presents on MRx0518 at Microbiome Movement - Drug Development Europe, Paris |
Document | (2,424KB) |
Link | — |
Date | 29 Jan 2019 |
Title | 4D pharma announces publication of data highlighting immuno-stimulatory properties of MRx0518 |
Document | — |
Link | visit |
Date | 28 Nov 2018 |
---|---|
Title | Chardan Microbiome Medicines Landscape Webinar |
Document | — |
Link | visit |
Date | 29 Oct 2018 |
Title | 4D pharma present on efficacy of asthma candidate MRx-4DP0004 in a model of severe asthma, Microbiome R&D and Business Collaboration Forum, San Diego, USA |
Document | (1,058KB) |
Link | — |
Date | 11 Oct 2018 |
Title | 4D Key Opinion Leader Luncheon: Immuno-oncology |
Document | (4,087KB) |
Link | visit |
Date | 02 Oct 2018 |
Title | 4D present on discovery and development of microbiome-based therapeutics in asthma and immuno-oncology, Microbiome Summit, Vienna, Austria |
Document | (1,676KB) |
Link | — |
Date | 16 Sep 2018 |
Title | 4D present on mechanisms of asthma programme MRx0004, EMBO/EMBL Symposia: The Human Microbiome, Heidelberg, Germany |
Document | (860KB) |
Link | — |
Date | 14 Aug 2018 |
Title | 4D asthma publication |
Document | — |
Link | visit |
Date | 30 Jul 2018 |
Title | Publication - microbiota as HDAC inhibitors |
Document | — |
Link | visit |
Date | 27 Jun 2018 |
Title | 4D presents, Live Biotherapeutics: Form Follows Functions, at IHMC 2018 |
Document | (1,593KB) |
Link | visit |
Date | 26 Jun 2018 |
Title | 4D present data on IBS microbiome analysis at IHMC Conference, Killarney, Ireland |
Document | (866KB) |
Link | — |
Date | 26 Jun 2018 |
Title | 4D present data on gut bacterial strains able to modulate neuroinflammation and neurodegeneration, IHMC Conference, Killarney, Ireland |
Document | (525KB) |
Link | — |
Date | 04 Jun 2018 |
Title | 4D Presents Phase Ib Clinical Data on Blautix |
Document | (457KB) |
Link | visit |
Date | 04 Jun 2018 |
Title | Live Biotherapeutics - From Concept to Clinic in Immuno-Oncology |
Document | (1,987KB) |
Link | — |
Date | 21 Mar 2018 |
Title | 4D presents data on MRx0518 MoA in immuno-oncology |
Document | (1,215KB) |
Link | — |
Date | 12 Feb 2018 |
Title | Live biotherapeutics and immuno-oncology: from discovery to efficacy studies, Cell-Weizmann Institute of Science Symposium: Next Gen Immunology Congress, Rehovot, Isreal |
Document | (927KB) |
Link | — |